Levitra Related Published Studies
Well-designed clinical trials related to Levitra (Vardenafil)
Effect of vardenafil on blood pressure profile of patients with erectile dysfunction concomitantly treated with doxazosin gastrointestinal therapeutic system for benign prostatic hyperplasia. [2008.09]
Effect of Vardenafil on Blood Pressure Profile of Patients With Erectile Dysfunction Concomitantly Treated With Doxazosin Gastrointestinal Therapeutic System for Benign Prostatic Hyperplasia. [2008.07.16]
A double-blind, placebo-controlled, randomized clinical study of the effects of vardenafil on human nasal patency. [2008.05]
Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury. [2008.04.01]
Daily vardenafil for 6 months has no detrimental effects on semen characteristics or reproductive hormones in men with normal baseline levels. [2008.03]
Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study. [2007.11]
Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data. [2007.10]
The Treatment Satisfaction Scale (TSS) is a sensitive measure of treatment effectiveness for both patients and partners: results of a randomized controlled trial with vardenafil. [2007.07]
Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners. [2007.07]
Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners. [2007.05.04]
The efficacy and safety of vardenafil in East Asian men with erectile dysfunction. [2007.05]
Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naive men with ED and their partners. [2006.11]
Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction. [2006.09]
The effect of vardenafil on endothelial function of brachial and cavernous arteries. [2006.09]
Efficacy and safety of vardenafil in renal transplant recipients with erectile dysfunction. [2006.06]
Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives. [2005.11]
Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial. [2005.11]
Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study. [2005.10]
Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. [2005.09]
Vardenafil in patients with erectile dysfunction: achieving treatment optimization. [2005.09]
Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis. [2005.06]
Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. [2005.06]
[Efficacy and tolerability of vardenafil within the time window of 6 hours after administration and beyond. Results of a clinical study carried out in 233 urological offices] [2005.04.07]
[Efficacy and safety of oral vardenafil in the treatment of erectile dysfunction] [2004.12]
Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial. [2004.12]
Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. [2004.11]
Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction. [2004.09]
Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial. [2004.09]
Safety and efficacy of vardenafil in patients with erectile dysfunction: result of a bridging study in Japan. [2004.07]
Evaluation of vardenafil and sildenafil on cardiac repolarization. [2004.06.01]
The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European men. [2004.05]
Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction. [2004.03]
Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. [2003.10]
Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups. [2003.09]
Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial. [2003.04]
Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction. [2003.03]
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. [2003.03]
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. [2002.12.04]
Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose. [2001.08]
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. [2001.08]
Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study. [2001.02]
Well-designed clinical trials possibly related to Levitra (Vardenafil)
Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence. [2008.05]
Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence. [2008.01.10]
Responsiveness and minimum important differences for the erection quality scale. [2007.11]
Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. [2005.04]
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. [2004.11]
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. [2004.10.06]
Other research related to Levitra (Vardenafil)
Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. [2008.10]
Intravenous tezosentan and vardenafil attenuate acute hypoxic pulmonary hypertension. [2008.09]
Effect of Nightly versus On-Demand Vardenafil on Recovery of Erectile Function in Men Following Bilateral Nerve-Sparing Radical Prostatectomy. [2008.07.09]
Comparable Efficacy of Once-Daily Versus On-Demand Vardenafil in Men with Mild-to-Moderate Erectile Dysfunction: Findings of the RESTORE Study. [2008.07]
Vardenafil in men with stable statin therapy and dyslipidemia. [2008.06]
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. [2008.06]
Vardenafil demonstrates first-dose success and reliability of penetration and maintenance of erection in men with erectile dysfunction - RELY-II. [2008.06]
Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets. [2008.06]
Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction. [2008.05]
Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKG. [2008.05]
Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. [2008.03.01]
The effect of physician and patient education when combined with vardenafil treatment in Canadian males with erectile dysfunction: an open-label, factorial-designed, cluster-randomized clinical trial. [2008.03]
The impact of formulary replacement of sildenafil by vardenafil at a local VA hospital. [2008.03]
A Randomised, Placebo-Controlled Study to Assess the Efficacy of Twice-Daily Vardenafil in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. [2008.02.04]
Vardenafil in the treatment of erectile dysfunction in outpatients with chronic schizophrenia: a flexible-dose, open-label study. [2008.02]
The effect of vardenafil (a PDE type 5 inhibitor) on renal function in the diabetic rabbit: a pilot study. [2007.09]
[A clinical study of sertralin and vardenafil in the treatment of premature ejaculation complicated by erectile dysfunction] [2007.07]
Post-marketing surveillance study of the efficacy and safety of vardenafil among patients with erectile dysfunction in primary care. [2007.07]
Effects of vardenafil on intraocular pressure and orbital hemodynamics. [2007.06]
Vardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunction. [2007.05]
Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? [2007.05]
The COUPLES-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment. [2007.04]
[Effects of Huafenqinutang and vardenafil for treatment of chronic prostatitis/chronic pelvic pain syndrome with concomitant erectile dysfunction] [2007.04]
Efficacy of vardenafil and influence on self-esteem and self-confidence in patients with severe erectile dysfunction. [2007.03]
Real-life safety and efficacy of vardenafil in the treatment of erectile dysfunction-results from 30,010 U.S. patients. [2007.03]
Vardenafil and weaning from inhaled nitric oxide: effect on pulmonary hypertension in ARDS. [2007.02]
Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS). [2007.02]
Vardenafil restores erectile function to normal range in men with erectile dysfunction. [2007.01]
The real-life safety and efficacy of vardenafil: an international post-marketing surveillance study of 2824 patients from the Middle East. [2007]
First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-I. [2006.11]
Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study. [2006.11]
Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study. [2006.11]
Antidepressant-induced inhibition of genital vascular responses is reversed by vardenafil in female rabbits. [2006.11]
[Efficacy and safety of vardenafil in the treatment of erectile dysfunction in men with hypertension] [2006.10]
[Safety and tolerability of Vardenafil] [2006.09]
Vardenafil improved erectile function in a "real-life" broad population study of men with moderate to severe erectile dysfunction in Australia and New Zealand. [2006.09]
Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. [2006.08]
Vardenafil rescue rates of sildenafil nonresponders: objective assessment of 327 patients with erectile dysfunction. [2006.08]
Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction. [2006.08]
Treatment strategy for "non-responders" to tadalafil and vardenafil: a real-life study. [2006.07]
[Reliable efficacy of vardenafil for treatment of erectile dysfunction] [2006.07]
Simultaneous administration of vardenafil and alcohol does not result in a pharmacodynamic or pharmacokinetic interaction in healthy male subjects. [2006.05]
[Epileptic seizures and vardenafil] [2006.05]
[Efficacy and safety of vardenafil in difficult-to-treat erectile dysfunction men] [2006.04]
Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits. [2006.03]
Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. [2006.03]
Long-term vardenafil therapy improves hemodynamics in patients with pulmonary hypertension. [2006.02]
Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. [2006.01.24]
Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. [2006.01]
Flexible-dose vardenafil in a community-based population of men affected by erectile dysfunction: a 12-week open-label, multicenter trial. [2005.11]
Atrial fibrillation after vardenafil therapy. [2005.11]
Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis. [2005.09]
[Evaluating the treatment satisfaction of vardenafil in men with erectile dysfunction and female partners by the Treatment Satisfaction Scale] [2005.09]
Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor. [2005.08]
|
